- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by GELCAB
Total 70 results
-
GenmabTerminatedRheumatoid ArthritisUnited States, Canada
-
GenmabCompletedCutaneous T-Cell LymphomaUnited Kingdom, Germany, United States, Sweden
-
GenmabCompletedHead and Neck Cancer | Squamous Cell CancerSweden, United Kingdom, France, Hungary, Canada, Brazil, Belgium, Lithuania, Russian Federation, Serbia, Estonia, Poland
-
GenmabRecruitingNon-Hodgkin Lymphoma | Classical Hodgkin LymphomaUnited States, Australia
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia
-
GenmabCompletedHead and Neck Cancer | Squamous Cell CancerUnited States, Germany, Israel, Colombia, Czechia, Austria, Chile, Italy, Peru, Portugal, Slovakia
-
GenmabCompletedMelanoma | Sarcoma | Cervical Cancer | Ovarian Cancer | Endometrial Cancer | Solid Tumors | Thyroid Cancer | Non Small Cell Lung Cancer (NSCLC)United States, United Kingdom, Belgium, Denmark, Netherlands, Spain
-
GenmabTerminatedColorectal CancerBelgium
-
GenmabCompletedCutaneous T-Cell LymphomaUnited States
-
GenmabRecruitingSquamous Non Small Cell Lung Cancer (NSCLC-SCC) | Breast Cancer, Breast Neoplasms | Endometrial Cancer, Endometrial Neoplasm | Ovarian Cancer, Ovarian NeoplasmsUnited States, France, Spain, Netherlands, Belgium, United Kingdom, Denmark, Italy, Poland
-
GenmabTerminatedHead and Neck Cancer | Squamous Cell CarcinomaUnited Kingdom, Belgium, France
-
GenmabCompletedHead and Neck CancerUnited Kingdom, Belgium, Slovakia, Hungary
-
GenmabTerminatedRenal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Urothelial CancerUnited States, United Kingdom, Spain
-
GenmabTerminatedHead and Neck Cancer | Squamous Cell CancerBelgium, Sweden, United States, France, Netherlands
-
GenmabTerminatedNon Small Cell Lung CancerBelgium, United States, France, Netherlands, United Kingdom
-
GenmabWithdrawnNon-small Cell Lung Cancer
-
AbbVieGenmabRecruitingDiffuse Large B-Cell Lymphoma | Classic Follicular LymphomaUnited States, Puerto Rico
-
GenmabAbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, United Kingdom, Belgium, Denmark, Netherlands, Finland, Czechia, Sweden, Australia, Norway
-
GenmabAbbVieActive, not recruitingDiffuse Large B-cell LymphomaKorea, Republic of, Spain, Taiwan, Belgium, France, Israel, United Kingdom, China, United States, Netherlands, Japan, Sweden, Turkey, Australia, Singapore, Germany, Denmark, Poland, Italy, Hungary, Austria, Russian Federation, Norway, Canad... and more
-
GenmabAbbVieActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell LymphomaJapan
-
GlaxoSmithKlineGenmabCompletedLeukaemia, Lymphocytic, ChronicSweden
-
AbbVieGenmabRecruitingFollicular Lymphoma (FL)Austria, Greece, Israel, Korea, Republic of, Spain, Hungary, Sweden, Switzerland, France, Poland, Taiwan, Australia, Denmark, New Zealand, Turkey, Italy, Netherlands, Belgium, Canada, South Africa, Czechia, Brazil, Germany, Argentina, United... and more
-
AbbVieGenmabRecruitingNon-Hodgkin LymphomaUnited States, France, Israel, Korea, Republic of, Spain, Taiwan, Netherlands, Czechia, Japan, Hungary, Germany, Denmark
-
AbbVieGenmabRecruitingNon-hodgkin LymphomaUnited States, Australia, France, Israel, Korea, Republic of, Spain, Taiwan, Japan, Italy, Belgium, Germany, Canada, Turkey, Czechia
-
GenmabAbbVieRecruitingSmall Lymphocytic Lymphoma | Richter's Syndrome | Relapsed/Refractory Chronic Lymphocytic LeukemiaUnited States, Belgium, Netherlands, Spain, Italy, Australia, Israel, France, Denmark, Czechia, Germany, United Kingdom
-
GenmabAbbVieActive, not recruitingSmall Lymphocytic Lymphoma (SLL) | DLBCL | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | MCL | Marginal Zone Lymphoma (MZL) | High-grade B-cell Lymphoma (HGBCL) | FLKorea, Republic of, United States, Australia, Singapore, Netherlands, Sweden, France, Finland, United Kingdom, Spain, Germany, Denmark, Italy, Poland, Canada
-
AbbVieGenmabActive, not recruiting
-
GenmabAbbVieTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B-cell LymphomaUnited States, Spain, Netherlands, Belgium, France, Denmark
-
GenmabAbbVieTerminatedEsophageal Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer (NSCLC) | Uterine Cancer | Triple Negative Breast Cancer (TNBC) | Squamous Cell Carcinoma of Head and Neck (SCCHN) | Locally Advanced or Metastatic Solid Tumor(s)Spain, Israel, United States, Denmark
-
AbbVieGenmabRecruiting
-
GenmabAbbVieRecruitingDiffuse Large B Cell LymphomaFrance, Korea, Republic of, Spain, Belgium, Japan, Germany, Czechia, United Kingdom, Italy, Austria, United States, Poland
-
AbbVieGenmabRecruitingDiffuse Large B-Cell LymphomaKorea, Republic of, Spain, Japan, Israel, Australia, Poland, Netherlands, Sweden, Greece, Taiwan, Italy, Belgium, Denmark, Switzerland, France, Bulgaria, Hungary, Austria, New Zealand, Czechia, Croatia, Brazil, China, United States, Canada and more
-
GenmabAbbVieApproved for marketingPrimary Mediastinal Large B-cell Lymphoma (PMBCL) | Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-cell Lymphoma (HGBCL) | Grade 3B Follicular Lymphoma
-
GenmabBioNTech SERecruitingMalignant Solid TumorJapan
-
GenmabBioNTech SERecruiting
-
GenmabBioNTech SERecruitingMelanoma | Malignant Solid Tumor | Non Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC)United States, Taiwan, Spain, Israel, Korea, Republic of, France, Italy, Denmark, Germany, United Kingdom, Georgia, Moldova, Republic of
-
GenmabBioNTech SEActive, not recruitingSolid Tumor, AdultSpain, Georgia, Moldova, Republic of
-
GenmabBioNTech SEActive, not recruitingSolid Tumor, AdultSpain, United States
-
GenmabBioNTech SEActive, not recruiting
-
Seagen Inc.GenmabCompletedBladder Cancer | Cervix Cancer | Ovary Cancer | Esophagus Cancer | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Endometrium Cancer | Prostate Cancer (CRPC) | Lung Cancer(NSCLC)United States, Belgium, United Kingdom, Denmark, Sweden
-
Seagen Inc.GenmabCompletedBladder Cancer | Cervix Cancer | Ovary Cancer | Esophagus Cancer | Endometrium Cancer | Prostate Cancer (CRPC) | Lung Cancer (NSCLC)United States, United Kingdom, Belgium, Hungary, Denmark
-
Seagen Inc.GenmabRecruitingCervical CancerUnited States, Canada, Japan, Austria, Belgium, China, France, Korea, Republic of, Netherlands, Singapore, Spain, United Kingdom, Argentina, Brazil, Germany, Italy, Norway, Peru, Poland, Finland, Denmark, Ireland, Czechia, Hungary, Taiwan, Swed... and more
-
GenmabSeagen Inc.Completed
-
Seagen Inc.GenmabCompletedProstate Cancer | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Cervix Cancer | Lung Cancer, Nonsmall Cell | Ovary Cancer | Esophagus Cancer | Endometrium CancerUnited States, United Kingdom
-
BioNTech SEGenmabRecruitingAdvanced Malignant Solid TumorUnited States, United Kingdom
-
GenmabBioNTech SENot yet recruitingAdvanced Endometrial CancerKorea, Republic of, Spain, Belgium, United States, Denmark, Italy
-
GenmabBioNTech SEActive, not recruitingCervical Cancer | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Solid Tumors | Endometrial Carcinoma | Urothelial CarcinomaUnited States, Spain, Israel, Czechia, Georgia, Italy, Poland, Turkey, Hungary, Ukraine
-
Seagen Inc.GenmabCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Spain, Belgium, Denmark, Ireland, Italy